Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;12(23):21419-21425.
doi: 10.1002/cam4.6689. Epub 2023 Nov 6.

Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data

Garrett Kearney  1 , Ming-Hui Chen  2 , Layth Mula-Hussain  3 , Mac Skelton  4 , Mehmet Fuat Eren  5 , Peter F Orio  1 , Paul L Nguyen  1 , Anthony V D'Amico  1 , Mutlay Sayan  1
Affiliations

Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data

Garrett Kearney et al. Cancer Med. 2023 Dec.

Abstract

Background: Prostate cancer represents a significant global health issue, yet our understanding of its impact in the Middle East remains limited. This study aimed to assess the incidence and mortality of prostate cancer in the Middle East, and compare these rates to those in Europe and North America.

Materials and methods: We utilized the 2020 Global Cancer Observatory data, compiling incidence and mortality rates of prostate cancer in 20 Middle Eastern countries. We calculated mortality-to-incidence ratios (MIR) and compared the age-standardized incidence rate (ASIR) and MIR between the Middle East and the combined regions of North America and Europe. The countries were further stratified based on the Human Development Index (HDI) and income level for additional analysis.

Results: In 2020, the Middle East documented an estimated 51,649 new prostate cancer diagnoses, accounting for 3.7% of global cases. Despite a significantly lower ASIR in the Middle East compared with Europe and North America (10.50 vs. 21.50, p = 0.0087), the region had a higher MIR (12.35 vs. 3.00, p = 0.0476). When stratified based on HDI or income levels, there was no significant difference in MIRs; however, a significant trend of increasing MIR with decreasing HDI (p = 0.028) and income levels (p = 0.016) was observed.

Conclusions: Despite a lower incidence, our analysis showed a significantly higher MIR for prostate cancer in the Middle East compared with Europe and North America. These findings underscore the unique challenges posed by prostate cancer in the Middle East and emphasize the necessity of tailored strategies to address this pressing public health issue.

Keywords: clinical observations; epidemiology and prevention; prostate cancer; risk assessment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate cancer. Cold Spring Harb Perspect Med. 2018;8(12):a030361. - PMC - PubMed
    1. Park SY, Haiman CA, Cheng I, et al. Racial/ethnic differences in lifestyle‐related factors and prostate cancer risk: the multiethnic cohort study. Cancer Causes Control. 2015;26:1507‐1515. - PMC - PubMed
    1. Kazmi N, Haycock PC, Tsilidis KK, et al. Appraising causal relationships of dietary, nutritional and physical‐activity exposures with overall and aggressive prostate cancer: two‐sample mendelian‐randomization study based on 79 148 prostate‐cancer cases and 61106 controls. Int J Epidemiol. 2019;49:587‐596. - PubMed
    1. Layne TM, Graubard BI, Ma X, Mayne ST, Albanes D. Prostate cancer risk factors in black and white men in the NIH‐AARP diet and health study. Prostate Cancer Prostatic Dis. 2018;22:91‐100. - PMC - PubMed
    1. Ali AH, Awada H, Nassereldine H, et al. Prostate cancer in the Arab world: bibliometric review and research priority recommendations. Arab J Urol. 2022;20(2):81‐87. - PMC - PubMed